Display options
Share it on

Radiol Bras. 2021 Mar-Apr;54(2):77-82. doi: 10.1590/0100-3984.2020.0018.

Intravenous contrast use and acute kidney injury: a retrospective study of 1,238 inpatients undergoing computed tomography.

Radiologia brasileira

Thyago A Coser, Juliana S V Leitão, Betina M Beltrame, Luciano S Selistre, Leandro Tasso

Affiliations

  1. Universidade de Caxias do Sul (UCS), Caxias do Sul, RS, Brazil.

PMID: 33854260 PMCID: PMC8029938 DOI: 10.1590/0100-3984.2020.0018

Abstract

OBJECTIVE: To determine the incidence of nephropathy induced by intravenous contrast in hospitalized patients undergoing computed tomography (CT).

MATERIALS AND METHODS: This was a retrospective cohort study involving 1,238 patients who underwent CT with or without intravenous administration of a contrast agent (iopromide). The primary outcome measure was acute kidney injury (AKI), as defined by the traditional criteria-an absolute or relative increase in serum creatinine (SCr) ≥ 0.5 mg/dL or ≥ 25% over baseline, respectively, at 2-3 days after contrast administration-and the newer, Kidney Disease: Improving Global Outcomes (KDIGO) criteria-an absolute or relative increase in SCr ≥ 0.3 mg/dL or ≥ 50% over baseline, respectively, at 2-7 days after contrast administration.

RESULTS: The overall incidence of AKI was 11.52% when the KDIGO criteria were applied. Univariate logistic regression demonstrated a significant association between an absolute post-CT increase in SCr ≥ 0.5 mg/dL and AKI, although that association did not retain significance in the multivariate analysis. Multivariate logistic regression initially found an association between an absolute post-CT increase in SCr ≥ 0.3 mg/dL and advanced age, although that association was not maintained after correction. We found no association between AKI and the risk factors evaluated.

CONCLUSION: We identified no criteria for contrast-induced nephropathy after CT; nor did we find AKI to be associated with the classical risk factors.

Keywords: Acute kidney injury; Contrast media/administration & dosage; Contrast media/adverse effects; Creatinine/blood; Iodine radioisotopes; Tomography, X-ray computed

References

  1. Lancet. 2017 Apr 1;389(10076):1312-1322 - PubMed
  2. Clin Radiol. 2018 Apr;73(4):389-390 - PubMed
  3. Radiology. 2013 Apr;267(1):106-18 - PubMed
  4. Nephron. 2019;141(1):31-40 - PubMed
  5. Nephrol Dial Transplant. 2005 Aug;20(8):1542-50 - PubMed
  6. Nephrol Dial Transplant. 2018 Oct 1;33(10):1751-1756 - PubMed
  7. Adv Chronic Kidney Dis. 2017 May;24(3):169-175 - PubMed
  8. AJR Am J Roentgenol. 2008 Aug;191(2):376-82 - PubMed
  9. Jpn J Radiol. 2017 Aug;35(8):427-431 - PubMed
  10. World Health Organ Tech Rep Ser. 1995;854:1-452 - PubMed
  11. Radiology. 2006 May;239(2):392-7 - PubMed
  12. Ann Emerg Med. 2017 May;69(5):577-586.e4 - PubMed
  13. Am J Kidney Dis. 2002 May;39(5):930-6 - PubMed
  14. Eur J Radiol. 2012 Oct;81(10):2554-61 - PubMed
  15. Radiology. 2014 Apr;271(1):65-73 - PubMed
  16. Eur J Radiol. 2013 Sep;82(9):e387-99 - PubMed
  17. Radiology. 2013 Apr;267(1):119-28 - PubMed
  18. Radiology. 2014 Dec;273(3):714-25 - PubMed
  19. Ann Emerg Med. 2015 Sep;66(3):267-274.e4 - PubMed
  20. Circulation. 2012 Jun 26;125(25):3099-107 - PubMed
  21. Radiology. 2013 Sep;268(3):719-28 - PubMed

Publication Types